Does VALPROATE Cause Dyslipidaemia? 44 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 44 reports of Dyslipidaemia have been filed in association with VALPROATE (Valproate Sodium). This represents 0.3% of all adverse event reports for VALPROATE.
44
Reports of Dyslipidaemia with VALPROATE
0.3%
of all VALPROATE reports
0
Deaths
40
Hospitalizations
How Dangerous Is Dyslipidaemia From VALPROATE?
Of the 44 reports, 40 (90.9%) required hospitalization, and 1 (2.3%) were considered life-threatening.
Is Dyslipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALPROATE. However, 44 reports have been filed with the FAERS database.
What Other Side Effects Does VALPROATE Cause?
Foetal exposure during pregnancy (1,982)
Drug ineffective (1,268)
Seizure (1,083)
Epilepsy (878)
Somnolence (843)
Off label use (744)
Drug abuse (705)
Sopor (577)
Dysmorphism (552)
Drug interaction (513)
What Other Drugs Cause Dyslipidaemia?
OLANZAPINE (230)
ROSUVASTATIN (206)
ARIPIPRAZOLE (185)
METHOTREXATE (175)
QUETIAPINE (161)
ATORVASTATIN (155)
RISPERIDONE (154)
METFORMIN (151)
TACROLIMUS (149)
ZIPRASIDONE (149)
Which VALPROATE Alternatives Have Lower Dyslipidaemia Risk?
VALPROATE vs VALPROIC ACID
VALPROATE vs VALPROMIDE
VALPROATE vs VALSARTAN
VALPROATE vs VALTREX
VALPROATE vs VAMOROLONE